At a glance
- Originator GlaxoSmithKline
- Developer GSK; Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 06 Dec 2000 Profile reviewed but no significant changes made
- 17 Apr 1997 No-Development-Reported for Cancer in Italy (Unknown route)
- 29 Mar 1995 New profile